QSAM Biosciences, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, D. Brooks and Associates CPA's P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
QSAM Biosciences, Inc.
Equities
QSAM
US74738N2027
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +7.10% | +3.75% | +36.07% |
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.77% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- QSAM Stock
- News QSAM Biosciences, Inc.
- QSAM Biosciences, Inc. Auditor Raises 'Going Concern' Doubt